DK1364029T3 - Fusionsprotein, der omfatter hirudin og proinsulin eller insulin - Google Patents
Fusionsprotein, der omfatter hirudin og proinsulin eller insulinInfo
- Publication number
- DK1364029T3 DK1364029T3 DK02711847T DK02711847T DK1364029T3 DK 1364029 T3 DK1364029 T3 DK 1364029T3 DK 02711847 T DK02711847 T DK 02711847T DK 02711847 T DK02711847 T DK 02711847T DK 1364029 T3 DK1364029 T3 DK 1364029T3
- Authority
- DK
- Denmark
- Prior art keywords
- proinsulin
- hirudin
- insulin
- fusion protein
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10108212A DE10108212A1 (de) | 2001-02-20 | 2001-02-20 | Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1364029T3 true DK1364029T3 (da) | 2006-05-08 |
Family
ID=7674913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02711847T DK1364029T3 (da) | 2001-02-20 | 2002-02-08 | Fusionsprotein, der omfatter hirudin og proinsulin eller insulin |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1364029B1 (xx) |
| JP (1) | JP4243104B2 (xx) |
| KR (1) | KR100858009B1 (xx) |
| CN (1) | CN100500853C (xx) |
| AT (1) | ATE314480T1 (xx) |
| AU (1) | AU2002231784B2 (xx) |
| BR (1) | BRPI0207394B8 (xx) |
| CA (1) | CA2438886C (xx) |
| DE (2) | DE10108212A1 (xx) |
| DK (1) | DK1364029T3 (xx) |
| ES (1) | ES2254658T3 (xx) |
| HK (1) | HK1065335A1 (xx) |
| IL (1) | IL157414A0 (xx) |
| MX (1) | MXPA03007114A (xx) |
| NO (1) | NO331271B1 (xx) |
| NZ (1) | NZ527643A (xx) |
| PE (1) | PE20020876A1 (xx) |
| WO (1) | WO2002068660A1 (xx) |
| ZA (1) | ZA200305869B (xx) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
| PL2327718T3 (pl) | 2003-11-21 | 2016-10-31 | Ulepszone systemy ekspresyjne z wykorzystaniem systemu sekrecji SEC | |
| KR101183720B1 (ko) | 2004-01-16 | 2012-09-17 | 다우 글로벌 테크놀로지스 엘엘씨 | 슈도모나스 플루오레센스에서의 포유류 단백질의 발현 |
| KR20130019457A (ko) | 2004-07-26 | 2013-02-26 | 다우 글로벌 테크놀로지스 엘엘씨 | 균주 조작에 의한 개선된 단백질 발현 방법 |
| DE102006031962A1 (de) | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Amidiertes Insulin Glargin |
| DE102006031955A1 (de) | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende |
| DE102006050332A1 (de) | 2006-10-25 | 2008-04-30 | Wacker Chemie Ag | DNS-Konstrukt und Verfahren zur fermentativen Herstellung von Fusionsproteinen |
| US7618799B2 (en) | 2007-01-31 | 2009-11-17 | Dow Global Technologies Inc | Bacterial leader sequences for increased expression |
| MX2009011523A (es) | 2007-04-27 | 2009-11-09 | Dow Global Technologies Inc | Metodo para clasificar rapidamente huespedes microbianos para identificar ciertas cepas con rendimiento y/o calidad mejorados en la expresion de proteinas heterologas. |
| US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| CN102007143B (zh) | 2008-01-09 | 2015-08-26 | 塞诺菲-安万特德国有限公司 | 具有超延迟时效特征的新型胰岛素衍生物 |
| DE102008025008A1 (de) | 2008-05-24 | 2009-11-26 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
| DE102008025007A1 (de) | 2008-05-24 | 2009-11-26 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
| AU2009203810B2 (en) | 2008-01-09 | 2013-07-25 | Sanofi-Aventis Deutschland Gmbh | Novel insulin derivatives having an extremely delayed time-action profile |
| DE102008003566A1 (de) | 2008-01-09 | 2009-07-16 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
| DE102008003568A1 (de) | 2008-01-09 | 2009-07-16 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
| US9018001B2 (en) | 2008-10-02 | 2015-04-28 | Unitargeting Research As | Kit for the optimisation of protein synthesis/secretion |
| PT3228320T (pt) | 2008-10-17 | 2020-03-26 | Sanofi Aventis Deutschland | Combinação de uma insulina e de um agonista do glp-1 |
| RU2537239C2 (ru) | 2009-11-13 | 2014-12-27 | Санофи-Авентис Дойчланд Гмбх | Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин |
| PT2498801T (pt) | 2009-11-13 | 2018-05-02 | Sanofi Aventis Deutschland | Composição farmacêutica compreendendo despro36exendin-4(1-39)-lys6-nh2 e metionina |
| RU2546520C2 (ru) | 2010-08-30 | 2015-04-10 | Санофи-Авентис Дойчланд Гмбх | Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| ES2550357T3 (es) | 2011-08-29 | 2015-11-06 | Sanofi-Aventis Deutschland Gmbh | Combinación farmacéutica para su uso en el control glucémico en pacientes de diabetes de tipo 2 |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| US11084860B2 (en) | 2013-03-12 | 2021-08-10 | The General Hospital Corporation | Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases |
| CA3151082A1 (en) | 2013-12-11 | 2015-06-18 | The General Hospital Corporation | Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation |
| HUE062573T2 (hu) | 2014-12-12 | 2023-11-28 | Sanofi Aventis Deutschland | Glargin inzulin/lixiszenatid rögzített arányú készítmény |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0158564B1 (fr) * | 1984-03-27 | 1992-07-15 | Transgene S.A. | Vecteurs d'expression de l'hirudine, cellules transformées et procédé de préparation de l'hirudine |
| GB8927722D0 (en) * | 1989-12-07 | 1990-02-07 | British Bio Technology | Proteins and nucleic acids |
| ATE176500T1 (de) * | 1990-11-08 | 1999-02-15 | Japan Energy Corp | Sekretionsvektor, diesen enthaltene transformierte mikroorganismen und herstellung von produkten durch obigen mikroorganismus |
| CA2128689A1 (en) * | 1992-09-28 | 1995-04-06 | Harold T. Pehr | Kicker latch for container closures |
| DE10033195A1 (de) * | 2000-07-07 | 2002-03-21 | Aventis Pharma Gmbh | Bifunktionale Fusionsproteine aus Hirudin und TAP |
-
2001
- 2001-02-20 DE DE10108212A patent/DE10108212A1/de not_active Withdrawn
-
2002
- 2002-02-06 PE PE2002000081A patent/PE20020876A1/es not_active Application Discontinuation
- 2002-02-08 ES ES02711847T patent/ES2254658T3/es not_active Expired - Lifetime
- 2002-02-08 AU AU2002231784A patent/AU2002231784B2/en not_active Expired
- 2002-02-08 DK DK02711847T patent/DK1364029T3/da active
- 2002-02-08 JP JP2002568754A patent/JP4243104B2/ja not_active Expired - Lifetime
- 2002-02-08 EP EP02711847A patent/EP1364029B1/en not_active Expired - Lifetime
- 2002-02-08 IL IL15741402A patent/IL157414A0/xx active IP Right Grant
- 2002-02-08 DE DE60208343T patent/DE60208343T2/de not_active Expired - Lifetime
- 2002-02-08 KR KR1020037010943A patent/KR100858009B1/ko active IP Right Grant
- 2002-02-08 MX MXPA03007114A patent/MXPA03007114A/es active IP Right Grant
- 2002-02-08 AT AT02711847T patent/ATE314480T1/de active
- 2002-02-08 NZ NZ527643A patent/NZ527643A/en not_active IP Right Cessation
- 2002-02-08 CA CA2438886A patent/CA2438886C/en not_active Expired - Lifetime
- 2002-02-08 CN CNB028068505A patent/CN100500853C/zh not_active Expired - Lifetime
- 2002-02-08 WO PCT/EP2002/001307 patent/WO2002068660A1/en active IP Right Grant
- 2002-02-08 BR BRPI0207394A patent/BRPI0207394B8/pt not_active IP Right Cessation
-
2003
- 2003-07-30 ZA ZA200305869A patent/ZA200305869B/en unknown
- 2003-08-19 NO NO20033673A patent/NO331271B1/no not_active IP Right Cessation
-
2004
- 2004-10-20 HK HK04108196.1A patent/HK1065335A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL157414A0 (en) | 2004-03-28 |
| NO331271B1 (no) | 2011-11-14 |
| KR100858009B1 (ko) | 2008-09-11 |
| JP2004518444A (ja) | 2004-06-24 |
| CA2438886A1 (en) | 2002-09-06 |
| EP1364029B1 (en) | 2005-12-28 |
| BRPI0207394B8 (pt) | 2021-05-25 |
| ZA200305869B (en) | 2004-06-25 |
| KR20030074842A (ko) | 2003-09-19 |
| WO2002068660A1 (en) | 2002-09-06 |
| DE60208343D1 (de) | 2006-02-02 |
| NO20033673D0 (no) | 2003-08-19 |
| JP4243104B2 (ja) | 2009-03-25 |
| EP1364029A1 (en) | 2003-11-26 |
| NO20033673L (no) | 2003-10-17 |
| PE20020876A1 (es) | 2002-11-05 |
| BRPI0207394B1 (pt) | 2015-06-16 |
| BR0207394A (pt) | 2004-02-10 |
| NZ527643A (en) | 2005-07-29 |
| HK1065335A1 (en) | 2005-02-18 |
| AU2002231784B2 (en) | 2006-10-26 |
| DE10108212A1 (de) | 2002-08-22 |
| CN100500853C (zh) | 2009-06-17 |
| DE60208343T2 (de) | 2006-06-22 |
| MXPA03007114A (es) | 2003-11-18 |
| ES2254658T3 (es) | 2006-06-16 |
| CN1529757A (zh) | 2004-09-15 |
| ATE314480T1 (de) | 2006-01-15 |
| CA2438886C (en) | 2013-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1364029T3 (da) | Fusionsprotein, der omfatter hirudin og proinsulin eller insulin | |
| WO2005021592A3 (en) | Enhancing the circulating half-life of interleukin-2 proteins | |
| EE200100223A (et) | Interferoon-beetaga sulandatud valgud ja nende kasutamine | |
| NZ521396A (en) | Fusion proteins comprising two or more Neisseria polypeptides | |
| DE60325892D1 (de) | Stellungs- und verwendungsverfahren | |
| DE60238541D1 (de) | Modifizierte transferrin-fusionsproteine | |
| DK1699822T3 (da) | IL-7-fusionsproteiner med antistofdele, fremstilling deraf og anvendelse deraf | |
| ZA200308589B (en) | Recombinant fusion proteins and the trimers thereof. | |
| DK1346034T3 (da) | von Willebrand-faktor (vWF) spaltende protease-polypeptid, nukleinsyre kodende for polypeptidet og anvendelse af polypeptidet | |
| WO2004061080A3 (en) | Stress-related polypeptides and uses therefor | |
| DK1481059T3 (da) | Eukaryote signalsekvenser for polypeptidekspression og polypeptiddisplaybiblioteker | |
| DE50312184D1 (de) | Streptavidin-bindungspeptid | |
| DE60118935D1 (de) | Dna & protein bindende miniatur proteine | |
| EP1558729A4 (en) | QUICKLY REMOVED REPORTER FUSION PROTEINS | |
| DK1539221T3 (da) | Transferrin-fusionsproteinbiblioteker | |
| ATE550345T1 (de) | Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren | |
| NO20005081D0 (no) | Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav | |
| AU2002258630A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| AU2003287108A1 (en) | Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production | |
| BR0315222A (pt) | Promotor de il-18bp, sua preparação e uso | |
| AU2002303137A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| EP1379678A4 (en) | HUMAN PROTEASE ISOLATED PROTEINS, NUCLEIC ACID MOLECULES ENCODING HUMAN PROTEASE PROTEINS AND USES THEREOF | |
| WO2003016465A3 (en) | Cell cycle regulator protein | |
| IL204767A (en) | Stable chimeric oligomeric proteins for denture and protease resistant | |
| NO910331D0 (no) | Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner. |